Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SOX9-transactived long non-coding RNA NEAT1 promotes the self-renewal of liver cancer stem cells through PKA/Hippo signaling. | Signal Transduct Target Ther | 2021 | 33633109 | PubTator, text mining | PubMed |
| The protein phosphatase PPM1A dephosphorylates and activates YAP to govern mammalian intestinal and liver regeneration. | PLoS Biol | 2021 | 33630828 | PubTator, text mining | PubMed |
| Extracts of Perilla frutescens var. Acuta (Odash.) Kudo Leaves Have Antitumor Effects on Breast Cancer Cells by Suppressing YAP Activity. | Evid Based Complement Alternat Med | 2021 | 33628300 | PubTator, text mining | PubMed |
| Long non-coding RNA VPS9D1-AS1 facilitates cell proliferation, migration and stemness in hepatocellular carcinoma. | Cancer Cell Int | 2021 | 33627127 | PubTator, text mining | PubMed |
| Epigenetically modulated miR-1224 suppresses the proliferation of HCC through CREB-mediated activation of YAP signaling pathway. | Mol Ther Nucleic Acids | 2021 | 33614242 | PubTator, text mining | PubMed |
| Long noncoding RNAs as tumorigenic factors and therapeutic targets for renal cell carcinoma. | Cancer Cell Int | 2021 | 33593347 | PubTator, text mining | PubMed |
| Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of KITLG and DKK1 genes in glioma SCs in vitro. | Mol Ther Oncolytics | 2021 | 33575478 | PubTator, text mining | PubMed |
| DNA Methylation in T-Cell Acute Lymphoblastic Leukemia: In Search for Clinical and Biological Meaning. | Int J Mol Sci | 2021 | 33573325 | PubTator, text mining | PubMed |
| MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway. | J Biol Chem | 2021 | 33571521 | PubTator, text mining | PubMed |
| The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis. | Genes Dis | 2021 | 33569513 | PubTator, text mining | PubMed |
| Upregulation of LINC01426 promotes the progression and stemness in lung adenocarcinoma by enhancing the level of SHH protein to activate the hedgehog pathway. | Cell Death Dis | 2021 | 33568633 | PubTator, text mining | PubMed |
| MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer. | Pharmaceuticals (Basel) | 2021 | 33562150 | PubTator, text mining | PubMed |
| Targeting the Hippo Pathway in Prostate Cancer: What's New? | Cancers (Basel) | 2021 | 33557087 | PubTator, text mining | PubMed |
| Negative feedback couples Hippo pathway activation with Kibra degradation independent of Yorkie-mediated transcription. | Elife | 2021 | 33555257 | PubTator, text mining | PubMed |
| Identification of New Genes Involved in Germline Predisposition to Early-Onset Gastric Cancer. | Int J Mol Sci | 2021 | 33525650 | PubTator, text mining | PubMed |
| Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target. | Mol Oncol | 2021 | 33523558 | PubTator, text mining | PubMed |
| Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma. | J Neurooncol | 2021 | 33511508 | PubTator, text mining | PubMed |
| Arsenic exposure in Indo Gangetic plains of Bihar causing increased cancer risk. | Sci Rep | 2021 | 33504854 | PubTator, text mining | PubMed |
| A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer. | J Exp Clin Cancer Res | 2021 | 33499877 | PubTator, text mining | PubMed |
| Hippo Signaling Pathway in Gliomas. | Cells | 2021 | 33477668 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=66